Dubousset Functional Test: An Investigation of Its Validity and Reliability in Children With GMFCS I-II Spastic Cerebral Palsy

NCT06831591 | Completed

• 1 other identifier: Dobousset
• Study Type: observational
• Target: 33
• Locations: 1 country
• Sites: 1

Brief Summary

the investigators hypothesize that over time, it may lead to loss of functional capacity in children with CP. In this context, our study aims to examine the validity and reliability of the four-component Dubousset Functional Test (DFT), which is used to objectively measure the functional capacity of children with spastic CP, in children with spastic cerebral palsy at Gross Motor Function Classification System (GMFCS) I-II level.

Conditions

Cerebral Palsy (CP); Reliability and Validity; Functional Test; Gross Motor Function Classification System (GMFCS) Level I,II

Outcome Measures

Primary Outcomes (1)

• Dubousset Functional Test

  Investigation of the Validity and Reliability of the Dubousset Functional Test in Children with GMFCS I-II Spastic Cerebral Palsy. It is a test used to objectively measure the functional capacity of children with spastic CP. The DFT includes 4 different test components. After the patients are administered the DFT, they will rest for 1 hour and then the DFT will be administered again. The time to complete the tests will be recorded in seconds and evaluated before and after.

  1 days

Secondary Outcomes (5)

• TUG (Timed Up and Go) Test

  Day 1

• Dual Task TUG (Additional Cognitive Task)

  Day 1

• Three-Meter Backward Walk Test (3MBWT)

  day 1

• Functional Reach Test

  day 1

• Pediatric Balance Scale

  day 1

Study Arms (1)

gmfcs 1-2

It was conducted on individuals diagnosed with spastic CP at GMFCS level I-II.

Eligibility Criteria

• Age: 12 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

G-Power 3.1.9.2 program was used to estimate the required sample size and it was observed that the effect obtained in the reference study was at a strong level (d = 0.731) (Lexell JE, Downham DY, 2005). As a result of the power analysis performed with the assumption that this effect size could be obtained again, it was calculated that 95% statistical power would be obtained at 95% confidence level if at least 33 people were included in the study.

You may qualify if:

• years old,
• Diagnosed with spastic cerebral palsy,
• GMFCS level I-II,
• At the appropriate cognitive level to adapt to the tests to be performed in the study,
• Completed primary school level,
• Individuals who agree to participate in the study will be recruited.

You may not qualify if:

• Bone and/or soft tissue surgery on the lower extremities within the last 1 year,
• Inability to perform a task due to sensory, cognitive or other problems,
• Ataxic CP, Dyskinetic CP, Hypotonic CP, Mixed type CP groups will not be included in the study.

Sponsors & Collaborators

• Inonu University: lead

Study Sites (1)

Kayseri City Hospital, Physical Medicine and Rehabilitation Clinic

Kayseri, 38000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, Chronic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: research assistant

Study Record Dates

• First Submitted: February 6, 2025
• First Posted: February 18, 2025
• Study Start: January 24, 2025
• Primary Completion: February 1, 2025
• Study Completion: March 1, 2025
• Last Updated: August 28, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)